Department of Medicine, University of Louisville, Louisville, KY, USA.
Life Sci. 2013 Aug 28;93(7):257-64. doi: 10.1016/j.lfs.2013.06.016. Epub 2013 Jun 22.
Type 1 and Type 2 diabetic patients are at high risk of developing diabetic nephropathy (DN). Renal functional decline is gradual and there is high variability between patients, though the reason for the variability is unknown. Enough diabetic patients progress to end stage renal disease to make diabetes the leading cause of renal failure. The first symptoms of DN do not appear for years or decades after the onset of diabetes. During and after the asymptomatic period structural changes develop in the diabetic kidney. Typically, but not always, the first symptom of DN is albuminuria. Loss of renal filtration rate develops later. This review examines the structural abnormalities of diabetic kidneys that are associated with and possibly the basis for advancing albuminuria and declining GFR. Mouse models of diabetes and genetic manipulations of these models have become central to research into mechanisms underlying DN. This article also looks at the value of these mouse models to understanding human DN as well as potential pitfalls in translating the mouse results to humans.
1 型和 2 型糖尿病患者发生糖尿病肾病 (DN) 的风险很高。尽管其原因尚不清楚,但肾脏功能的下降是逐渐发生的,而且患者之间存在很大的变异性。足够数量的糖尿病患者进展为终末期肾病,使糖尿病成为肾衰竭的主要原因。DN 的最初症状在糖尿病发病后数年或数十年后才出现。在无症状期期间和之后,糖尿病肾脏会发生结构变化。通常,但并非总是如此,DN 的第一个症状是白蛋白尿。随后会出现肾小球滤过率下降。本文综述了与白蛋白尿和肾小球滤过率下降进展相关的、可能是其基础的糖尿病肾脏的结构异常。糖尿病小鼠模型和对这些模型的遗传操作已成为研究 DN 发病机制的核心。本文还探讨了这些小鼠模型在理解人类 DN 中的价值,以及将小鼠结果转化为人类时的潜在陷阱。